Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

4 SC AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

21 Feb 2015 Reuters Investment Profile 12 $20.00

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review Summary 4SC AG (4SC) discovers and develops targeted therapies fo...

04 Feb 2015 GlobalData 51 $125.00

4SC - DEUTSCHES EIGENKAPITALFORUM

4SC is primarily focused on preparing a Phase II study with resminostat in first-line liver cancer, aimed at confirming the d...

28 Jan 2015 Edison Investment Research 2 $10.00

Is 4 Sc AG Worth a Higher Bid?

21 Jan 2015 Sadif Analytics Prime 12 $25.00

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review Summary 4SC AG (4SC) discovers and develops targeted therapies fo...

06 Jan 2015 GlobalData 49 $125.00

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review Summary 4SC AG (4SC) discovers and develops targeted therapies fo...

05 Dec 2014 GlobalData 56 $125.00

4 Sc AG: Downgraded to Below Average

19 Nov 2014 Sadif Analytics Prime 3 $10.00

4SC - PARTNER ACCELERATES RESMINOSTAT DEVELOPMENT

While 4SC focuses on securing the fresh finance and/or partner required to conduct a Phase IIb study for resminostat in liver...

18 Nov 2014 Edison Investment Research 6 $10.00

Will 4 Sc AG Deliver Top-Shelf Performance?

29 Oct 2014 Sadif Analytics Prime 12 $25.00

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review

4SC AG (VSC) - Financial and Strategic SWOT Analysis Review Summary 4SC AG (4SC) discovers and develops targeted therapies fo...

15 Oct 2014 GlobalData 56 $125.00